Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2.
A primate lymphotropic lentivirus was isolated on the human T-cell line HuT 78 after cocultivation of a lymph node from a pig-tailed macaque (Macaca nemestrina) that had died with malignant lymphoma. This isolate, originally designated M. nemestrina immunodeficiency virus (MnIV) and now classified as simian immunodeficiency virus (SIV/Mne), was inoculated intravenously into three juvenile rhesus monkeys (Macaca mulatta), three juvenile pig-tailed macaques (M. nemestrina), and two juvenile baboons (Papio cynocephalus). All six macaques became viremic by 3 weeks after inoculation, whereas neither of the baboons developed viremia. One pig-tailed macaque died at 15 weeks with suppurative peritonitis secondary to ulcerative, necrotizing colitis. Immunologic abnormalities included a marked decrease in CD4+ peripheral blood lymphocytes. Although five macaques mounted an antibody response to SIV/Mne, the animal that died at 15 weeks remained antibody negative. Three other macaques (two rhesus and one pig-tailed) died 66 to 87 weeks after inoculation after exhibiting progressive weight loss, anemia, and diarrhea. Histopathologic findings at necropsy included various manifestations of immune deficiency, nephropathy, subacute encephalitis, pancreatitis, adenocarcinoma, and lymphoid atrophy. SIV/Mne could be readily isolated from the spleens and lymph nodes of all necropsied macaques, and from the cerebrospinal fluid, brains, bone marrow, livers, and pancreas of some of the animals. SIV antigens were localized by avidin-biotin immunohistochemistry to pancreatic islet cells and to bone marrow endothelial cells. The data suggest that African baboons may be resistant to infection by SIV/Mne, whereas Asian macaques are susceptible to infection with this pathogenic primate lentivirus.
Benveniste
R E
RE
Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick, Maryland 21701-1013.
Morton
W R
WR
Clark
E A
EA
Tsai
C C
CC
Ochs
H D
HD
Ward
J M
JM
Kuller
L
L
Knott
W B
WB
Hill
R W
RW
Gale
M J
MJ
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D001853:Bone Marrow / Q000276:immunology; D005921:Glomerulonephritis / Q000473:pathology; D007163:Immunosorbent Techniques; D007958:Leukocyte Count; D008198:Lymph Nodes / Q000276:immunology / Q000382:microbiology; D008251:Macaca / Q000276:immunology / Q000382:microbiology*; D010215:Papio / Q000276:immunology / Q000382:microbiology*; D012190:Retroviridae / Q000276:immunology / Q000472:pathogenicity*; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology
D000914:Antibodies, Viral; D000945:Antigens, Differentiation, T-Lymphocyte; D000956:Antigens, Viral